Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension
Tajima, J.; Abe, K.; Yasujima, M.; Tanno, M.; Yoshinaga, K.
Nihon Jinzo Gakkai Shi 26(6): 779-789
1984
ISSN/ISBN: 0385-2385 PMID: 6096607 Document Number: 226307
Document emailed within 1 workday
Related Documents
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9Rasmussen, S.; Ibsen, H.; Giese, J. 1984: Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension Scandinavian Journal of Urology and Nephrology. Supplementum 79: 49-52
Ramirez, A.J.; Migliorini, M.; Gilbert, B.H.; Marco, E.J.; Sanchez, R.A. 1991: Non-modulating essential hypertension: renal hemodynamic effects of long-term angiotensin converting enzyme inhibition Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 9(6): S396-S397
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Waeber, B.; Burnier, M.; Nussberger, J.; Brunner, H.R. 1987: Renal function after administration of angiotensin-converting enzyme inhibitors Schweizerische Medizinische Wochenschrift 117(37): 1359-1362
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Kondo, K.; Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Morotomi, Y.; Tanaka, K. 1985: Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system Nihon Jinzo Gakkai Shi 27(3): 337-342
Almazov, V.A.; Ametov, A.S.; Shliakhto, E.V.; Dolgova, I.B.; Pushkarev, A.A. 1989: Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme Terapevticheskii Arkhiv 61(8): 13-15
Spieker, C.; Zidek, W.; Vetter, H.; Rahn, K.H. 1991: Ambulatory 24-h blood pressure monitoring in essential hypertensives treated with the angiotensin-converting enzyme inhibitor ramipril Journal of International Medical Research 19(1): 39-43
Shulman, N.B. 1988: Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors Journal of the National Medical Association 80(3): 265-272
Zhou, H.; Bian, Y-fei.; Li, M-lian.; Gao, F.; Xiao, C-shi. 2010: Effects of RNA interference targeting angiotensin 1 receptor and angiotensin-converting enzyme on blood pressure and myocardial remodeling in spontaneous hypertensive rats Zhonghua Xin Xue Guan Bing Za Zhi 38(1): 60-66
Gheorghiade, M.; Hall, V.B.; Jacobsen, G.; Alam, M.; Rosman, H.; Goldstein, S. 1995: Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92(7): 1801-1807
Karlberg, B.E.; Fyhrquist, F.; Grönhagen-Riska, C.; Tikkanen, I.; Ohman, K.P. 1984: Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report Scandinavian Journal of Urology and Nephrology. Supplementum 79: 103-106
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Graziano, M.J.; Dethloff, L.A.; Griffin, H.E.; Pegg, D.G. 1993: Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats Archives Internationales de Pharmacodynamie et de Therapie 324: 87-104
Brazhnik, V.A.; Gorashko, N.M.; Minushkina, L.O.; Zateĭshchikov, D.A.; Zateĭshchikova, A.A.; Nosikov, V.V.; Sidorenko, B.A. 2003: Polymorphic markers I/D and G7831A of angiotensin-I-converting enzyme gene and left ventricular hypertrophy in patients with essential hypertension Kardiologiia 43(2): 44-49
Esther, C.R.; Howard, T.E.; Marino, E.M.; Goddard, J.M.; Capecchi, M.R.; Bernstein, K.E. 1996: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility Laboratory Investigation; a Journal of Technical Methods and Pathology 74(5): 953-965
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422